+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biodegradable Type Embolic Microspheres Market - Global Forecast 2025-2030- Product Image
Biodegradable Type Embolic Microspheres Market - Global Forecast 2025-2030- Product Image
Sale

Biodegradable Type Embolic Microspheres Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6080370
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biodegradable embolic microspheres are redefining the landscape of interventional radiology by offering a sustainable and clinically advanced solution for precise vascular and oncological procedures. This comprehensive market research delivers actionable insights on the technological, regulatory, and commercial trends shaping this rapidly evolving sector for stakeholders aiming to drive innovation and growth.

Market Snapshot: Biodegradable Embolic Microspheres

This report analyzes the biodegradable embolic microsphere market, assessing recent market developments, emerging technologies, and evolving adoption trends. As an alternative to permanent embolic materials, biodegradable microspheres are gaining traction due to the demand for safer, more effective interventions and materials that support environmental and patient safety objectives. Advanced manufacturing and personalized medicine are fueling market expansion, while trade regulations and reimbursement frameworks are introducing new dynamics for manufacturers and healthcare providers.

Scope & Segmentation

This research segmentizes the market for deeper analysis and more targeted strategy development. The following are the core segmentation lenses analyzed:

  • Product Type
    • Drug-Eluting: Including doxorubicin and irinotecan formulations tailored for oncology and targeted therapies.
    • Non-Drug-Eluting: Designed for interventions such as arteriovenous malformations, providing temporary occlusion without chronic foreign-material risks.
  • Application
    • Arteriovenous Malformations
    • Liver Cancer: Both metastatic lesions and primary tumors benefit from innovative device designs.
    • Prostate Cancer
    • Uterine Fibroids: Emphasis on outpatient procedures to reduce symptoms and preserve fertility.
  • End User
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
  • Regional Coverage
    • Americas: United States, Canada, Mexico, Brazil, Argentina (key states: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio)
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Companies Profiled
    • Boston Scientific Corporation
    • Terumo Corporation
    • Merit Medical Systems, Inc.
    • Cook Medical LLC
    • Medtronic plc
    • AngioDynamics, Inc.
    • Guerbet S.A.
    • MicroVention, Inc.
    • BioSphere Medical, Inc.
    • Biocompatibles UK Ltd

Key Takeaways

  • Biodegradable embolic microspheres are establishing new safety and efficacy benchmarks, with resorbable materials that reduce foreign-body response and chronic complications.
  • Integration with drug-eluting technologies enables localized, high-concentration delivery of agents such as doxorubicin and irinotecan, expanding their value in complex oncology and benign vascular interventions.
  • Multidisciplinary collaborations between clinicians, scientists, and manufacturers are accelerating clinical protocol refinement, device optimization, and regulatory approvals in multiple regions.
  • Ambulatory surgical centers and specialty clinics, alongside hospitals, are driving broader adoption, particularly for outpatient and targeted procedures like uterine fibroid embolization.
  • Adoption drivers and infrastructure readiness differ regionally, with the Americas and Asia-Pacific showing strong investment, while emerging markets are leveraging partnerships and knowledge transfer for capacity building.
  • Market participants prioritizing post-market surveillance, adaptive commercial models, and real-world evidence generation are best positioned to navigate changing regulatory and reimbursement terrain.

Tariff Impact on Supply Chains & Manufacturer Strategies

New U.S. trade tariffs on critical inputs, such as polylactic-co-glycolic acid, are prompting producers to revise procurement strategies and explore alternative supply sources to maintain competitive pricing. Manufacturers are adopting measures like regional partnerships, nearshoring, and buffer stock management to navigate cost pressures and reduce exposure to logistics volatility.

Methodology & Data Sources

This analysis integrates primary interviews with clinicians, engineers, and regulatory leaders, combined with a systematic review of peer-reviewed literature, clinical trial databases, patent registries, and expert validation workshops. Both qualitative and quantitative approaches strengthen data reliability and ensure nuanced insights.

Why This Report Matters

  • Helps senior leaders identify strategic innovation and investment opportunities aligned with regulatory and clinical advancements in the biodegradable embolic microsphere sector.
  • Supports competitive differentiation by providing granular segmentation, regional dynamics, and actionable recommendations for expansion and risk mitigation.

Conclusion

Biodegradable embolic microspheres are driving a transition toward safer and more sustainable interventional therapies. Organizations leveraging these insights stand to achieve operational agility and shape the next era of minimally invasive care.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of drug-eluting biodegradable microspheres for targeted liver tumor chemoembolization
5.2. Development of tunable degradation rate microspheres for customized embolization therapies
5.3. Integration of radiopaque biodegradable microspheres to enhance real-time fluoroscopic visibility
5.4. Advances in microfluidic manufacturing techniques for uniform microsphere size and drug loading
5.5. Comparative cost-effectiveness studies of biodegradable versus non-resorbable embolic agents in uterine fibroid treatment
5.6. Regulatory approval trajectories and reimbursement frameworks for next-generation biodegradable embolic products in North America and Europe
5.7. Emerging uses of biodegradable microspheres in peripheral arterial disease management and vascular malformations
5.8. Collaboration between nanotechnology and biodegradable polymers to improve sustained drug release profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biodegradable Type Embolic Microspheres Market, by Product Type
8.1. Introduction
8.2. Drug Eluting
8.2.1. Doxorubicin
8.2.2. Irinotecan
8.3. Non Drug Eluting
9. Biodegradable Type Embolic Microspheres Market, by Application
9.1. Introduction
9.2. Arteriovenous Malformations
9.3. Liver Cancer
9.3.1. Metastatic Lesions
9.3.2. Primary Tumors
9.4. Prostate Cancer
9.5. Uterine Fibroids
10. Biodegradable Type Embolic Microspheres Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Americas Biodegradable Type Embolic Microspheres Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Biodegradable Type Embolic Microspheres Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Biodegradable Type Embolic Microspheres Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Boston Scientific Corporation
14.3.2. Terumo Corporation
14.3.3. Merit Medical Systems, Inc.
14.3.4. Cook Medical LLC
14.3.5. Medtronic plc
14.3.6. AngioDynamics, Inc.
14.3.7. Guerbet S.A.
14.3.8. MicroVention, Inc.
14.3.9. BioSphere Medical, Inc.
14.3.10. Biocompatibles UK Ltd
15. Research AI16. Research Statistics17. Research Contacts18. Research Articles19. Appendix
List of Figures
FIGURE 1. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET: RESEARCHAI
FIGURE 22. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET: RESEARCHSTATISTICS
FIGURE 23. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET: RESEARCHCONTACTS
FIGURE 24. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DOXORUBICIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DOXORUBICIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY IRINOTECAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY IRINOTECAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY NON DRUG ELUTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY NON DRUG ELUTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY METASTATIC LESIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY METASTATIC LESIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRIMARY TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRIMARY TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 69. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 72. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 73. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 76. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 77. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. CANADA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 82. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 83. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 86. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 87. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. MEXICO BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 134. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 135. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 138. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 139. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. GERMANY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 144. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 145. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 148. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 149. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. FRANCE BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 164. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 165. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 168. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 169. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. ITALY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 174. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 175. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 178. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 179. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. SPAIN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 214. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 215. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 218. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 219. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. DENMARK BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 234. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 235. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 238. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 239. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. QATAR BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 244. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 245. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 248. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 249. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. FINLAND BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 274. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 275. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2018-2024 (USD MILLION)
TABLE 278. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANCER, 2025-2030 (USD MILLION)
TABLE 279. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. EGYPT BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2018-2024 (USD MILLION)
TABLE 284. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY DRUG ELUTING, 2025-2030 (USD MILLION)
TABLE 285. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. TURKEY BIODEGRADABLE TYPE EMBOLIC MICROSPHERES MARKET SIZE, BY LIVER CANC

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biodegradable Type Embolic Microspheres market report include:
  • Boston Scientific Corporation
  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Cook Medical LLC
  • Medtronic plc
  • AngioDynamics, Inc.
  • Guerbet S.A.
  • MicroVention, Inc.
  • BioSphere Medical, Inc.
  • Biocompatibles UK Ltd

Related Topics

Related Reports

Medical Grade PMMA Microspheres Market - Global Forecast 2025-2030 - Product Image

Medical Grade PMMA Microspheres Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Microspheres - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Microspheres - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 200 Pages
  • Global
From
Dry Unexpanded Microspheres Market - Global Forecast 2025-2030 - Product Image

Dry Unexpanded Microspheres Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Bioadhesive Microspheres Market Report and Forecast 2024-2032 - Product Image

Bioadhesive Microspheres Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Microspheres Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Microspheres Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.